Utility of PCA3 urine assay in Japanese men undergoing prostate biopsy.

被引：0
|
作者：
Okihara, K. [1 ]
Ochiai, A. [1 ]
Kamoi, K. [1 ]
Miki, T. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PCA3 PERMUTATION INCREASES THE PROSTATE BIOPSY YIELD
    Siegrist, Timothy
    Fracchia, John
    JOURNAL OF UROLOGY, 2011, 185 (04): : E397 - E397
  • [32] PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
    Ruffion, Alain
    Devonec, Marian
    Champetier, Denis
    Decaussin-Petrucci, Myriam
    Rodriguez-Lafrasse, Claire
    Paparel, Philippe
    Perrin, Paul
    Vlaeminck-Guillem, Virginie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 17767 - 17780
  • [33] Specificity of the APTIMA® PCA3 assay for prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 240 - 240
  • [34] Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy
    Akamatsu, Shusuke
    Terada, Naoki
    Takata, Ryo
    Kinoshita, Hidefumi
    Shimatani, Kimihiro
    Momozawa, Yukihide
    Yamamoto, Michio
    Tada, Harue
    Kawamorita, Naoki
    Narita, Shintaro
    Kato, Takuma
    Nitta, Masahiro
    Kandori, Shuya
    Koike, Yusuke
    Inazawa, Johji
    Kimura, Takahiro
    Kimura, Hiroko
    Kojima, Takahiro
    Terachi, Toshiro
    Sugimoto, Mikio
    Habuchi, Tomonori
    Arai, Yoichi
    Yamamoto, Shingo
    Matsuda, Tadashi
    Obara, Wataru
    Kamoto, Toshiyuki
    Inoue, Takahiro
    Nakagawa, Hidewaki
    Ogawa, Osamu
    JNCI CANCER SPECTRUM, 2022, 6 (01)
  • [35] Specificity of the APTIMA® PCA3 assay for prostate cancer
    Marks, LS
    Aubin, SMJ
    Deras, IL
    Brentano, S
    Blase, A
    Bodrug, S
    Macairan, ML
    Ko, TY
    Rittenhouse, HG
    Groskopf, J
    JOURNAL OF UROLOGY, 2006, 175 (04): : 175 - 176
  • [36] UTILITY OF CAPDETECT™ PCA3 SCORE WITH OTHER FACTORS TO IMPROVE PREDICTION OF PROSTATE BIOPSY OUTCOME
    Amberson, James B.
    Blase, Amy
    Cochran, James S.
    Groskopf, Jack
    Harper, William M., IV
    Johnston, William G., Jr.
    Kella, Naveen
    Koziol, Isaac
    Patsias, Georgis
    Rabin, Mark
    Rittenhouse, Harry
    Williams, Thomas H.
    Weber, Art
    JOURNAL OF UROLOGY, 2009, 181 (04): : 812 - 812
  • [37] Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies
    De Luca, Stefano
    Passera, Roberto
    Cappia, Susanna
    Bollito, Enrico
    Randone, Donato Franco
    Milillo, Angela
    Papotti, Mauro
    Porpiglia, Francesco
    BJU INTERNATIONAL, 2014, 114 (6B) : E56 - E61
  • [38] The value of the PCA3 assay in guiding decision which men with a negative prostate biopsy need immediate repeat biopsy: Preliminary European data
    Haese, A.
    Van Poppel, H.
    Marberger, M.
    Mulders, P.
    Abbou, C. C.
    Boccon-Gibod, L. S.
    Stenzl, A.
    Huland, H.
    De La Taille, A.
    Schalken, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 48 - 48
  • [39] Specificity of PCA3 molecular urine test for prostate cancer
    Groskopf, J.
    Deras, I.
    Walker, S.
    Blase, A.
    Desaulniers, M.
    Fradet, Y.
    Marks, L. S.
    Rittenhouse, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 665 - 666
  • [40] PSGR and PCA3 as Biomarkers for the Detection of Prostate Cancer in Urine
    Rigau, Marina
    Morote, Juan
    Carmen Mir, Maria
    Ballesteros, Carlos
    Ortega, Israel
    Sanchez, Alex
    Colas, Eva
    Garcia, Marta
    Ruiz, Anna
    Abal, Miguel
    Planas, Jacques
    Reventos, Jaume
    Doll, Andreas
    PROSTATE, 2010, 70 (16): : 1760 - 1767
12345